Radiotherapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Global radiotherapy market is forecasted to value over USD 7 billion by 2026 end and register a CAGR of over 4% from the forecast period 2019-2026.
Latest
technological advancements, increasing focus of increasing awareness regarding
the benefits and growing prevalence of cancer is driving the market. Based on
the figures released by WHO, cancer is one of the major life-threatening
diseases and it accounted for the deaths of around 9.7 million people worldwide
in 2018. The rising usage of particle therapy for the diagnosis of cancer alongside
improving reimbursement policy is boosting the market. Emerging markets
alongside rising investments of government and private sectors are fueling the
market growth. Improvements and further amendments in image-guided radiotherapy
are propelling the market.
The
market is classified into product type, type, application, end-user, and
region. In terms of type, the market is segmented into radiotherapy, internal
beam radiotherapy, systemic radiotherapy, and external beam radiotherapy.
External beam radiotherapy is expected to dominate the growth of the market.
The precision and accuracy offered by external beam radiotherapy for targeting
tumour is better than other methods, which is the primary reason for segment
proliferation. In addition, external beam radiotherapy offers less risk of
exposure to radiation. Due to these factors, end-users have opted for external
beam radiotherapy thus inflating the market.
Based
on product type, external beam radiotherapy is expected to achieve the highest
CAGR. Less maintenance and equipment costs of linear accelerators alongside
precise radiation offered by cyberknife is expected to bolster the market. The
360-degree radiation treatment offered by tomotherapy is adding further growth
opportunities thus spurring the market.
In
terms of application, prostate cancer segment of external beam radiotherapy is
expected to showcase significant growth over the forecast period. Minimally
long-term risks associated with external beam radiotherapy coupled with the
rising cases of prostate cancer is driving the growth of the market. In
addition, the growing adoption of external beam radiation therapy (EBRT)
systems for the treatment of breast cancer is expected to expand the market.
On
the basis of end-user, hospitals are expected to hold the major market share.
The rising cases of cancer have resulted in hospitals demanding more deployment
of advanced radiotherapy equipment which has stimulated the market. The rapid
expansion of hospitals in developed economies alongside favorable government
initiatives aimed towards hospitals inculcating more advanced radiotherapy
systems is boosting the market.
In
terms of regions, North America dictates the market growth. The easy
accessibility, high adoption of advanced diagnostic equipment and rising
healthcare expenditure in countries like Canada and the US are stimulating the
market in the region. Asia-Pacific region is expected to showcase exponential
growth during the forecast period. Rapidly improving healthcare infrastructure
alongside growing per capita income in emerging economies like China, Japan and
India are bolstering the market in the region. In addition, favorable policies
launched by the governments of these countries are expected to boost the market
growth in the region.
Major
players of the market are Hitachi Ltd., IsoRay Medical, Inc, Ion Beam Applications SA,
Provision Healthcare, Varian Medical Systems, Inc, Mevion Medical Systems, Inc,
Panacea Medical Technologies Pvt.Ltd, Accuray Incorporated and Elekta AB.
Competitive Landscape:
● Varian Medical Systems in 2017, opened its center in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil
● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans
● Varian Medical Systems in 2017, opened its center in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil
● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans
Request a
Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=2347&page=requestsample
Global Radiotherapy Market Segmentation
By Product Type
● External Beam Radiotherapy
▪ Linear Accelerators
▪ Particle Therapy System
▪ Conventional Cobalt-60 Teletherapy Units
● Internal Beam Radiotherapy/Brachytherapy
▪ Seeds
▪ Applicators
▪ Afterloaders
▪ Electronic Brachytherapy Products
● Systemic Radiotherapy
▪ Iobenguane (I-131)
▪ Samarium-153
▪ Rhenium-186
By Type
● External Beam Radiotherapy
▪ Image-Guided Radiotherapy
▪ 3d Conformal Radiotherapy
▪ Intensity-Modulated Radiotherapy
▪ Stereotactic Therapy
▪ Particle Therapy
● Internal Beam Radiotherapy
▪ Low-Dose-Rate Brachytherapy
▪ High-Dose-Rate Brachytherapy
▪ Pulsed-Dose-Rate Brachytherapy
● Systemic Radiotherapy
▪ Intravenous Radiotherapy
▪ Oral Radiotherapy
▪ Instillation Radiotherapy
By Application
● External Beam Radiation Therapy
▪ Prostate Cancer
▪ Breast Cancer
▪ Lung Cancer
▪ Head and Neck Cancer
▪ Colorectal Cancer
▪ Other Cancers
● Internal Beam Radiotherapy/Brachytherapy
▪ Prostate Cancer
▪ Gynecological Cancer
▪ Breast Cancer
▪ Cervical Cancer
▪ Penile Cancer
▪ Other Cancers
By End User
● Hospital
● Independent Radiotherapy Centers
By Region:
● North America
● Europe
● Asia Pacific
● Latin America
● Rest of the World
By Product Type
● External Beam Radiotherapy
▪ Linear Accelerators
▪ Particle Therapy System
▪ Conventional Cobalt-60 Teletherapy Units
● Internal Beam Radiotherapy/Brachytherapy
▪ Seeds
▪ Applicators
▪ Afterloaders
▪ Electronic Brachytherapy Products
● Systemic Radiotherapy
▪ Iobenguane (I-131)
▪ Samarium-153
▪ Rhenium-186
By Type
● External Beam Radiotherapy
▪ Image-Guided Radiotherapy
▪ 3d Conformal Radiotherapy
▪ Intensity-Modulated Radiotherapy
▪ Stereotactic Therapy
▪ Particle Therapy
● Internal Beam Radiotherapy
▪ Low-Dose-Rate Brachytherapy
▪ High-Dose-Rate Brachytherapy
▪ Pulsed-Dose-Rate Brachytherapy
● Systemic Radiotherapy
▪ Intravenous Radiotherapy
▪ Oral Radiotherapy
▪ Instillation Radiotherapy
By Application
● External Beam Radiation Therapy
▪ Prostate Cancer
▪ Breast Cancer
▪ Lung Cancer
▪ Head and Neck Cancer
▪ Colorectal Cancer
▪ Other Cancers
● Internal Beam Radiotherapy/Brachytherapy
▪ Prostate Cancer
▪ Gynecological Cancer
▪ Breast Cancer
▪ Cervical Cancer
▪ Penile Cancer
▪ Other Cancers
By End User
● Hospital
● Independent Radiotherapy Centers
By Region:
● North America
● Europe
● Asia Pacific
● Latin America
● Rest of the World
Purchase
a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=2347&page=askfordiscount
FutureWise Key Takeaways
● Growth Prospects
● SWOT Analysis
● Key Trends
● Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global radiotherapy market by type, by product type, by application, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies
About FutureWise Research:
We specialise
in high-growth niche markets, assuring flexibility, agility and customised
solutions for our clients. Through in-depth market insights and consultancy, we
present our clients with the tools they need to be at the forefront of their
industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise
Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Comments
Post a Comment